account_id none on file
legal_name Zentalis Pharmaceuticals, Inc.
ticker ZNTL
cik 1725160
domain zentalis.com
linkedin_company_url https://www.linkedin.com/company/zentalis-pharmaceuticals
entry_point_account_id none on file
name Zentalis Pharmaceuticals Inc.
exchange Nasdaq
sector Health Care
sector index/company/sector/health-care/
calls 0 filings 12 executives 3 family 0
why_nownone on file
callsnone on file
filings
General and administrative expenses also include legal fees relating to intellectual property and corporate matters; professional fees for accounting, auditing, tax and consulting services; insurance costs; travel expenses; and facility-related expenses, which include direct depreciation costs and allocated expenses for rent and maintenance of facilities and other operating costs.
filing / Aug 6, 2026 / receipt
• costs of outside consultants, including their fees, non-cash stock-based compensation and related travel expenses; • the costs of laboratory supplies and acquiring, developing and manufacturing preclinical study and clinical trial materials; • license payments made for intellectual property used in research and development activities; and • allocated expenses for rent and maintenance of facilities and other o
filing / Aug 6, 2026 / receipt
In connection with the Restructuring, the Company recorded restructuring charges of $ 7.8 million primarily consisting of employee separation costs which are reported as a separate line item in the accompanying condensed consolidated statement of operations for the three and six months ended June 30, 2025.
filing / Aug 6, 2026 / receipt
The Company has completed all of the activities included in the restructuring plan as of December 31, 2025 and all of the costs associated with the restructuring were incurred during the quarter ended March 31, 2025.
filing / Aug 6, 2026 / receipt
On March 6, 2023, we entered into a sublease agreement pursuant to which we sublet the office space located at 1359 Broadway, Suites 1710 and 1800 in New York, New York to a subtenant.
filing / Aug 6, 2026 / receipt
As a result of the hybrid working environment, we may also face increased cybersecurity risks due to our reliance on internet technology and the number of our employees who are working remotely, which may create additional opportunities for cybercriminals to exploit vulnerabilities.
filing / Aug 6, 2026 / receipt
General and administrative expenses also include legal fees relating to intellectual property and corporate matters; professional fees for accounting, auditing, tax and consulting services; insurance costs; travel expenses; and facility-related expenses, which include direct depreciation costs and allocated expenses for rent and maintenance of facilities and other operating costs.
filing / May 12, 2026 / receipt
• costs of outside consultants, including their fees, non-cash stock-based compensation and related travel expenses; • the costs of laboratory supplies and acquiring, developing and manufacturing preclinical study and clinical trial materials; 27 • license payments made for intellectual property used in research and development activities; and • allocated expenses for rent and maintenance of facilities and ot
filing / May 12, 2026 / receipt
In connection with the Restructuring, the Company recorded restructuring charges of $ 7.8 million primarily consisting of employee separation costs which are reported as a separate line item in the accompanying condensed consolidated statement of operations for the three months ended March 31, 2025.
filing / May 12, 2026 / receipt
The Company has completed all of the activities included in the restructuring plan as of December 31, 2025 and all of the costs associated with the restructuring were incurred during the quarter ended March 31, 2025.
filing / May 12, 2026 / receipt
On March 6, 2023, we entered into a sublease agreement pursuant to which we sublet the office space located at 1359 Broadway, Suites 1710 and 1800 in New York, New York to a subtenant.
filing / May 12, 2026 / receipt
As a result of the hybrid working environment, we may also face increased cybersecurity risks due to our reliance on internet technology and the number of our employees who are working remotely, which may create additional opportunities for cybercriminals to exploit vulnerabilities.
filing / May 12, 2026 / receipt
executives
| Cam S. Gallagher | President | - | receipt |
| David M. Johnson | Chairman of the Board | - | receipt |
| Julie Eastland | Chief Executive Officer | - | receipt |
familynone on file
upcoming
| 2026-11-09 | earnings call | scheduled | ir |
changes
| 2024-11-13 | Chief Executive Officer, appointed | sec_8k |
| 2024-04-11 | Chief Financial Officer, departed | sec_8k |
| 2022-05-31 | President, appointed | sec_8k |
| 2022-05-16 | Chairman of the Board, appointed | sec_8k |
mcp_package_hint
slug zentalis-pharmaceuticals-inc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$